| Role of insulin resistance in human disease GM Reaven Diabetes 37 (12), 1595-1607, 1988 | 21373* | 1988 |
| Hypertension and associated metabolic abnormalities—the role of insulin resistance and the sympathoadrenal system GM Reaven, H Lithell, L Landsberg New England Journal of Medicine 334 (6), 374-382, 1996 | 2369 | 1996 |
| Pathophysiology of insulin resistance in human disease GM Reaven Physiological reviews 75 (3), 473-486, 1995 | 1949 | 1995 |
| Role of insulin resistance in human disease (syndrome X): an expanded definition GM Reaven Annual review of medicine 44 (1), 121-131, 1993 | 1496 | 1993 |
| Use of metabolic markers to identify overweight individuals who are insulin resistant T McLaughlin, F Abbasi, K Cheal, J Chu, C Lamendola, G Reaven Annals of internal medicine 139 (10), 802-809, 2003 | 1284 | 2003 |
| Fructose-induced insulin resistance and hypertension in rats. IS Hwang, H Ho, BB Hoffman, GM Reaven Hypertension 10 (5), 512-516, 1987 | 1194 | 1987 |
| Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration F Facchini, YDI Chen, CB Hollenbeck, GM Reaven Jama 266 (21), 3008-3011, 1991 | 1165 | 1991 |
| Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance I Zavaroni, E Bonora, M Pagliara, E Dall'Aglio, L Luchetti, G Buonanno, ... New England Journal of Medicine 320 (11), 702-706, 1989 | 1151 | 1989 |
| A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat MJ Reed, K Meszaros, LJ Entes, MD Claypool, JG Pinkett, TM Gadbois, ... Metabolism-Clinical and Experimental 49 (11), 1390-1394, 2000 | 1082 | 2000 |
| Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease G Reaven Circulation 106 (3), 286-288, 2002 | 1043 | 2002 |
| Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM GM Reaven, C Hollenbeck, CY Jeng, MS Wu, YDI Chen Diabetes 37 (8), 1020-1024, 1988 | 1040 | 1988 |
| Insulin resistance and cigarette smoking FS Facchini, CB Hollenbeck, J Jeppesen, YDI Chen, GM Reaven The Lancet 339 (8802), 1128-1130, 1992 | 1031 | 1992 |
| Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles GM Reaven, YDI Chen, J Jeppesen, P Maheux, RM Krauss The Journal of clinical investigation 92 (1), 141-146, 1993 | 1006 | 1993 |
| Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase KY Lin, A Ito, T Asagami, PS Tsao, S Adimoolam, M Kimoto, H Tsuji, ... Circulation 106 (8), 987-992, 2002 | 972 | 2002 |
| Relationship between obesity, insulin resistance, and coronary heart disease risk F Abbasi, BW Brown, C Lamendola, T McLaughlin, GM Reaven Journal of the American College of Cardiology 40 (5), 937-943, 2002 | 889 | 2002 |
| Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor MC Stühlinger, F Abbasi, JW Chu, C Lamendola, TL McLaughlin, ... Jama 287 (11), 1420-1426, 2002 | 852 | 2002 |
| The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals G Reaven Endocrinology and Metabolism Clinics 33 (2), 283-303, 2004 | 844 | 2004 |
| Insulin resistance as a predictor of age-related diseases FS Facchini, N Hua, F Abbasi, GM Reaven The Journal of Clinical Endocrinology & Metabolism 86 (8), 3574-3578, 2001 | 843 | 2001 |
| The metabolic syndrome: is this diagnosis necessary? 1, 2 GM Reaven The American journal of clinical nutrition 83 (6), 1237-1247, 2006 | 785 | 2006 |
| The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation RK Simmons, K Alberti, EAM Gale, S Colagiuri, J Tuomilehto, Q Qiao, ... Diabetologia 53, 600-605, 2010 | 761 | 2010 |
